Stay updated on BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedAdded new MedlinePlus Genetics topic on Multiple myeloma. This expands core content with a genetics-focused resource for a specific disease.SummaryDifference0.3%

- Check16 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma, reducing coverage of this specific condition.SummaryDifference0.3%

- Check23 days agoChange DetectedMajor change: page now announces v3.2.0 and includes an operation status notice due to funding lapse; removes the previous v3.1.0 reference.SummaryDifference4%

- Check30 days agoChange DetectedUpdate term from Plasma cell myeloma to Multiple myeloma and bump revision to v3.1.0 to reflect a newer version.SummaryDifference0.2%

- Check37 days agoChange DetectedAdded a new MedlinePlus Genetics topic focusing on multiple myeloma, expanding core content related to genetics and disease information.SummaryDifference0.3%

- Check44 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1, indicating a new release. The 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.